Login / Signup
Considerations for Defining Medication Exposure When Analyzing Real-World Data.
Alecia Clary
Nancy D Lin
Tamar Lasky
Matthew W Reynolds
Anand Chokkalingam
Carla Rodriguez-Watson
Published in:
Pharmacoepidemiology and drug safety (2023)
Keyphrases
</>
electronic health record
big data
healthcare
adverse drug
data analysis
artificial intelligence
deep learning